-
Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019
- Femke Overbosch1 , Mark de Boer2 , Karin Ellen Veldkamp3 , Pauline Ellerbroek4 , Chantal P Bleeker-Rovers5 , Bram Goorhuis6 , Michele van Vugt6 , Annemiek van der Eijk7 , Tjalling Leenstra8 , Martin Khargi9 , Jeanette Ros10 , Diederik Brandwagt11 , Manon Haverkate12 , Corien Swaan12 , Chantal Reusken7,12 , Aura Timen12,13 , Marion Koopmans7 , Jaap van Dissel2,12 , Lassa fever response team of The Netherlands14
-
View Affiliations Hide AffiliationsAffiliations: 1 Stichting BeroepsOpleiding Huisartsen (SBOH), Utrecht, the Netherlands 2 Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands 3 Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands 4 Department of Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands 5 Department of Internal Medicine, Division of Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands 6 Centre of Tropical Medicine and Travel Medicine, Amsterdam University Medical Center, location AMC, Amsterdam, the Netherlands 7 Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands 8 Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands 9 Department of Infectious Diseases, Public Health Service Hollands Midden, Leiden, the Netherlands 10 Department of Infectious Diseases, Public Health Service Kennemerland, Haarlem, the Netherlands 11 Department of Infectious Diseases, Public Health Service region Utrecht, Zeist, the Netherlands 12 National Institute for Public Health and the Environment (RIVM), Centre for Communicable Disease Control (CIb), Bilthoven, the Netherlands 13 Athena Institute, VU University Amsterdam, the Netherlands 14 The members of the Lassa fever response team of the Netherlands have been listed at the end of this articleAura Timenaura.timen rivm.nl
-
View Citation Hide Citation
Citation style for this article: Overbosch Femke, de Boer Mark, Veldkamp Karin Ellen, Ellerbroek Pauline, Bleeker-Rovers Chantal P, Goorhuis Bram, van Vugt Michele, van der Eijk Annemiek, Leenstra Tjalling, Khargi Martin, Ros Jeanette, Brandwagt Diederik, Haverkate Manon, Swaan Corien, Reusken Chantal, Timen Aura, Koopmans Marion, van Dissel Jaap, Lassa fever response team of The Netherlands. Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019. Euro Surveill. 2020;25(15):pii=2000265. https://doi.org/10.2807/1560-7917.ES.2020.25.15.2000265 Received: 06 Mar 2020; Accepted: 16 Apr 2020
Abstract
On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.
Article metrics loading...
Full text loading...
References
-
National Coordination Centre for Communicable Disease Control (LCI). Virale hemorragische koorts – arenavirussen. [Viral haemorrhagic fevers caused by arenaviruses]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2019. Dutch. Available from: https://lci.rivm.nl/richtlijnen/virale-hemorragische-koorts-arenavirussen
-
Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill. 2014;19(21):20817. https://doi.org/10.2807/1560-7917.ES2014.19.21.20817 PMID: 24906375
-
Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Günther S, van den Berkmortel F, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis. 2009;15(8):1171-5. https://doi.org/10.3201/eid1508.090015 PMID: 19751577
-
van Steenbergen J, Wijnands S. Public health management of fatal case of Lassa fever in the Netherlands. Euro Surveill. 2000;4(31):1552.
-
Veldkamp PJ, Schippers EF. Een man met fatale Lassa-koorts na een verblijf in Sierra Leone. [A man with fatal Lassa fever following a stay in Sierra Leone.] Ned Tijdschr Geneeskd. 2002;146(46):2201-4. Dutch. PMID: 12467165
-
World Health Organization (WHO). Lassa fever. Fact sheet. Geneva: WHO; 2017. http://origin.who.int/mediacentre/factsheets/fs179/en/
-
Okogbenin S, Okoeguale J, Akpede G, Colubri A, Barnes KG, Mehta S, et al. Retrospective cohort study of Lassa fever in pregnancy, Southern Nigeria. Emerg Infect Dis. 2019;25(8):1494-500. https://doi.org/10.3201/eid2508.181299 PMID: 31310586
-
World Health Organization (WHO). Lassa fever – the Netherlands (ex –Sierra Leone). Geneva: WHO; 2019. Available from: https://www.who.int/csr/don/27-november-2019-lassa-fever-netherlands_sierra_leone/en/
-
Garnett LE, Strong JE. Lassa fever: With 50 years of study, hundreds of thousands of patients and an extremely high disease burden, what have we learned? Curr Opin Virol. 2019;37:123-31. https://doi.org/10.1016/j.coviro.2019.07.009 PMID: 31479990
-
Kofman A, Choi MJ, Rollin PE. Lassa fever in travelers from West Africa, 1969-2016. Emerg Infect Dis. 2019;25(2):245-8. https://doi.org/10.3201/eid2502.180836 PMID: 30666924
-
Ogoina D. Lassa fever: A clinical and epidemiological review. Niger Delta J Med Med Res.2013;1(1):1-10.
-
Agboeze J, Nwali MI, Nwakpakpa E, Ogah OE, Onoh R, Eze J, et al. Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report. Int J Infect Dis. 2019;89:84-6. https://doi.org/10.1016/j.ijid.2019.08.023 PMID: 31465848
-
World Health Organization (WHO). Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. Geneva: WHO; 2014. Available from: https://apps.who.int/iris/handle/10665/130596
-
Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010;51(12):1435-41. https://doi.org/10.1086/657315 PMID: 21058912
-
Eberhardt KA, Mischlinger J, Jordan S, Groger M, Günther S, Ramharter M. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. Int J Infect Dis. 2019;87:15-20. https://doi.org/10.1016/j.ijid.2019.07.015 PMID: 31357056
-
Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, et al. Antibody therapy for Lassa fever. Curr Opin Virol. 2019;37:97-104. https://doi.org/10.1016/j.coviro.2019.07.003 PMID: 31401518
Data & Media loading...